Results 151 to 160 of about 35,241 (222)

FGFR2 NP_000132.3:p.N549H [PDF]

, 2020
openaire   +1 more source

Harmonization trial of <i>FGFR1-3</i> testing strategies in cholangiocarcinoma patients: an Italian multicenter experience. [PDF]

Pathologica
Pepe F, Russo G, Scimone C, Palumbo L, Tommasi S, Pinto R, De Biase D, Maloberti T, Busico A, Santoro A, Salemi D, Melucci E, Cozzolino D, Toffolatti L, Bessi S, Sarracino C, Tomaiuolo I, Minucci A, Roscigno G, Esposito F, Pallante P, Lonardi S, Pruneri G, Troncone G, Fassan M, Malapelle U.   +25 more
europepmc   +1 more source

FGFR2 NP_000132.3:p.S372C [PDF]

, 2020
openaire   +1 more source

Derazantinib enhances gemcitabine efficacy in PDAC by attenuating the NF-κB and MAPK pathways to suppress MUC5AC expression. [PDF]

Med Oncol
Ye W, Huang Y, Hong L, Ma Y, Huang J, Xu F, Han F, Qiu Y, Zou Z, Zhang Y, Li X.   +10 more
europepmc   +1 more source

FGFR2 alternative splicing

Reactome - a curated knowledgebase of biological pathways, 2016
openaire   +1 more source

FGFR2 NP_000132.3:p.Y375C [PDF]

, 2020
openaire   +1 more source

Unraveling the FGFR-RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose. [PDF]

Acta Pharm Sin B
Xian X, Gong R, Rong S, Zhang Z, Jia F, Li L, Chen Z, Eymin B, Jia T.   +8 more
europepmc   +1 more source

FGFR2 NP_000132.3:p.C382R [PDF]

, 2020
openaire   +1 more source

Knockdown of ALOX15 alleviates acute coronary syndrome via the FGFR2/PI3K/AKT signaling pathway. [PDF]

Biomed Rep
Chen H, Zhu N, Huang S, Guan F, Han S, Ye F, You L.   +6 more
europepmc   +1 more source

FGFR2 Gene Rearrangement [PDF]

, 2020
openaire   +1 more source